An Open MDx Platform

Fully Automated Liquid Handling
and Ultra-Fast qPCR

NGX 124 MDx diagnostics test platform
NGX 124 MDx diagnostics test platform
NGX 124 MDx diagnostics test platform

Open – Low Cost – High-Throughput – Mobile – LIMS integrated – Compact

The NGX 124 is a fully open, automated molecular diagnostics (MDx) test platform, offering a significant advantage over other systems.

It supports all Laboratory Developed Tests (LDTs), Research Use Only (RUO), and approved assays sourced directly from a wide range of small and medium sized assay manufacturers.

Technology

Jointly designed and developed by Fast MDx and Festo, the NGX 124 platform is the first fully automated, high-throughput, mobile Molecular Diagnostic (MDx) test platform and incorporates Fast MDx’s latest, ultra-fast, “NGx2” 4-Channel qPCR thermal cycler and Reverse Transcription “RT” block technology…

Specification

Compact, mobile and rugged on 4 lockable casters, the NGX 124 platform can be used anywhere in the World. Small enough to fit through any doorway and into any elevator, Fast MDx is as much at home in a biosecure laboratory as it is in a hospital facility…

Benefits

Fast MDx aims to provide affordable MDx to all peoples of the world, regardless of income or location…